NCT06749561

Brief Summary

Chemical peeling involves applying substances to the skin to induce controlled damage, which promotes the regeneration of fresh skin cells and enhances the skin's appearance.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 19, 2024

Last Update Submit

December 19, 2024

Conditions

Peeling Skin Syndrome

Outcome Measures

Primary Outcomes (1)

  • Dermatological Assessment Score (DAS)

    The area-wise percentage involvement of the involved sites is calculated as: 1 = less than 10% area; 2 = 10-29%; 3 = 30-49%; 4 = 50-69%; 5 = 70-89%; and 6 = more than 90%. The maximum score of PASI is 72. PASI 75 is a 75% reduction of baseline PASI score.

    12 Months

Interventions

Group 1DIAGNOSTIC_TEST

To Compare the safety and effectiveness of boyh types

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

To check the outcomes of Efficacy and Complications in Light and Deep Chemical Peels

You may qualify if:

  • Healthy males and females aged 18-35 years.
  • Willing to provide informed consent and follow the treatment protocol.

You may not qualify if:

  • Pregnant or breastfeeding women.
  • Active skin conditions (e.g., acne, eczema).
  • Use of medications that affect skin healing.
  • Known allergies to chemical peel substances.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Block E3 E-3 Gulberg III

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Peeling Skin Syndrome

Interventions

Chromosomes, Human, 1-3

Intervention Hierarchy (Ancestors)

Chromosomes, HumanChromosomes, MammalianChromosomesGenetic StructuresGenetic Phenomena

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2024

First Posted

December 27, 2024

Study Start

February 1, 2024

Primary Completion

August 1, 2024

Study Completion

March 1, 2025

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)